clinical trials

UniQure presses go on Huntington’s gene therapy trial
UniQure presses go on Huntington’s gene therapy trial
Pharmaforum
uniQure
Huntington's disease
gene therapy
AMT-130
clinical trials
Flag link:
An Alzheimer’s patient on what was lost when Biogen shut down its trial, and what may be gained again
An Alzheimer’s patient on what was lost when Biogen shut down its trial, and what may be gained again
Stat
Biogen
patients
Alzheimer's disease
aducanumab
clinical trials
Flag link:
Gilead’s filgotinib fails midphase tests in lupus, Sjogren's
Gilead’s filgotinib fails midphase tests in lupus, Sjogren's
Fierce Biotech
Gilead Sciences
filgotinib
lupus
Sjögren’s syndrome
clinical trials
Flag link:
Rubius' roller coaster ride set to accelerate with first clinical results
Rubius' roller coaster ride set to accelerate with first clinical results
Biopharma Dive
Rubius Therapeutics
clinical trials
phenylketonuria
Flag link:
RAPT Therapeutics announces initiation of first-in-human phase 1 study of RPT193
RAPT Therapeutics announces initiation of first-in-human phase 1 study of RPT193
Pharmaceutical Business Review
RAPT Therapeutics
RPT193
allergies
atopic dermatitis
clinical trials
Flag link:
MacroGenics' Metastatic Breast Cancer Drug Shows Survival Benefits in Phase III Trial
MacroGenics' Metastatic Breast Cancer Drug Shows Survival Benefits in Phase III Trial
BioSpace
Macrogenics
metastatic HER2-positive breast cancer
margetuximab
breast cancer
clinical trials
Flag link:
Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study
Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study
Endpoints
Provention Bio
JNJ
Crohn's Disease
clinical trials
PRV-6527
Flag link:
Worldwide Clinical Trials to Use Novel Platform to Address Phase I Trial Challenges
Worldwide Clinical Trials to Use Novel Platform to Address Phase I Trial Challenges
Xtalks
Worldwide Clinical Trials
clinical trials
CROs
Flag link:
Bristol-Myers makes Opdivo pitch for frontline lung cancer with open label PhIII study
Bristol-Myers makes Opdivo pitch for frontline lung cancer with open label PhIII study
Endpoints
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
advanced non-small cell lung cancer
clinical trials
Flag link:
Odonate Therapeutics announces completion of enrollment in CONTESSA metastatic breast cancer trial
Odonate Therapeutics announces completion of enrollment in CONTESSA metastatic breast cancer trial
Pharmaceutical Business Review
Odonate Therapeutics
metastatic breast cancer
clinical trials
Tesetaxel
Flag link:
Novartis' asthma drug fails in phase 3, raising doubts about Gossamer's prospects
Novartis' asthma drug fails in phase 3, raising doubts about Gossamer's prospects
Fierce Biotech
Novartis
clinical trials
fevipiprant
asthma
Gossamer Bio
Flag link:
Seattle Genetics' breast cancer drug hits mark in pivotal trial
Seattle Genetics' breast cancer drug hits mark in pivotal trial
Fierce Biotech
Seattle Genetics
clinical trials
HER2+ breast cancer
tucatinib
Flag link:
J&J’s Tremfya Shows Extended Success in Treating Plaque Psoriasis
J&J’s Tremfya Shows Extended Success in Treating Plaque Psoriasis
BioSpace
JNJ
Janssen
Tremfya
clinical trials
psoriasis
Flag link:
Novavax Begins Phase III Study on Influenza Vaccine Candidate
Novavax Begins Phase III Study on Influenza Vaccine Candidate
Yahoo/Zacks.com
Novavax
vaccines
clinical trials
influenza
NanoFlu
Flag link:
Helping Cancer Patients Navigate Clinical Trials
Helping Cancer Patients Navigate Clinical Trials
BioSpace
clinical trials
patients
cancer
Flag link:
Forbius completes enrollment into phase 1a solid tumour trial of AVID200
Forbius completes enrollment into phase 1a solid tumour trial of AVID200
Pharmaceutical Business Review
Forbius
fibrosis
cancer
AVID200
solid tumors
clinical trials
Flag link:
Reata shocks analysts with pivotal win in Friedreich's ataxia
Reata shocks analysts with pivotal win in Friedreich's ataxia
Fierce Biotech
Reata Pharmaceuticals
omaveloxolone
Friedreich's Ataxia
clinical trials
Flag link:
Staying Ahead of Biosimilar Competition, Roche's Rituxan Shows Superiority in Rare Autoimmune Skin Disease
Staying Ahead of Biosimilar Competition, Roche's Rituxan Shows Superiority in Rare Autoimmune Skin Disease
BioSpace
Roche
clinical trials
Rituxan/MabThera
MMF
pemphigus vulgaris
Flag link:
Pfizer posts detailed phase 3 data on its Dupixent rival
Pfizer posts detailed phase 3 data on its Dupixent rival
Fierce Biotech
Pfizer
clinical trials
atopic dermatitis
abrocitinib
Dupixent
Sanofi
Regeneron
Flag link:
Gilead, Galapagos share 52-week update on filgotinib
Gilead, Galapagos share 52-week update on filgotinib
Fierce Biotech
Gilead Sciences
Galapagos
filgotinib
clinical trials
rheumatoid arthritis
Flag link:

Pages